PAPP-A is involved in matrix mineralization of human adult mesenchymal stem cells and angiogenesis in the chick CAM

Julie Jadlowiec, Diana Dongell, Jason Smith, Cheryl A Conover, Phil Campbell

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Pregnancy-associated plasma protein A (PAPP-A) is an insulin-like growth factor binding protein 4 (IGFBP-4) protease that can function to increase local IGF-I bioavailability. Aside from its assumed role during pregnancy, in vitro and in vivo studies have indicated roles for PAPP-A in IGF-I-mediated wound healing, vascular repair and bone formation. As bone morphogenetic protein 2 (BMP-2) is known to up-regulate Igf-I gene expression, we hypothesized that PAPP-A may be involved in BMP-2 mechanisms in bone formation. To test this hypothesis, we quantified gene expression of Papp-A in response to BMP-2 treatment and Runx2, Osterix (Osx) and Igf-I in response to PAPP-A protein treatment in human adult mesenchymal stem cells (hMSC). Our results demonstrate that BMP-2 directly up-regulated Papp-A gene and protein expression. Purified PAPP-A protein directly up-regulated Runx2 and Igf-I gene expression, but not Osx. When added in combination with recombinant human BMP-2, PAPP-A increased matrix mineralization in the absence of dexamethasone. PAPP-A further demonstrated an angiogenic effect in the chick chorioallontoic membrane (CAM) which implicates a critical developmental role and possible therapeutic potential. Our findings suggest that PAPP-A functions in the formation of mineralized tissues through direct up-regulation of key genes. Further, PAPP-A is involved in the formation of new blood vessels which is essential for proper bone regeneration.

Original languageEnglish (US)
Pages (from-to)3765-3772
Number of pages8
JournalEndocrinology
Volume146
Issue number9
DOIs
StatePublished - Sep 2005

Fingerprint

Pregnancy-Associated Plasma Protein-A
Adult Stem Cells
Mesenchymal Stromal Cells
Membranes
Bone Morphogenetic Protein 2
Gene Expression
Insulin-Like Growth Factor I
Osteogenesis
Blood Vessels
Up-Regulation
Proteins
Bone Regeneration
Wound Healing
Dexamethasone
Biological Availability

Keywords

  • BMP-2
  • IGF-I
  • PAPP-A
  • Runx2

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

PAPP-A is involved in matrix mineralization of human adult mesenchymal stem cells and angiogenesis in the chick CAM. / Jadlowiec, Julie; Dongell, Diana; Smith, Jason; Conover, Cheryl A; Campbell, Phil.

In: Endocrinology, Vol. 146, No. 9, 09.2005, p. 3765-3772.

Research output: Contribution to journalArticle

Jadlowiec, Julie ; Dongell, Diana ; Smith, Jason ; Conover, Cheryl A ; Campbell, Phil. / PAPP-A is involved in matrix mineralization of human adult mesenchymal stem cells and angiogenesis in the chick CAM. In: Endocrinology. 2005 ; Vol. 146, No. 9. pp. 3765-3772.
@article{4243a27d50264e5c9f67b6017c07e496,
title = "PAPP-A is involved in matrix mineralization of human adult mesenchymal stem cells and angiogenesis in the chick CAM",
abstract = "Pregnancy-associated plasma protein A (PAPP-A) is an insulin-like growth factor binding protein 4 (IGFBP-4) protease that can function to increase local IGF-I bioavailability. Aside from its assumed role during pregnancy, in vitro and in vivo studies have indicated roles for PAPP-A in IGF-I-mediated wound healing, vascular repair and bone formation. As bone morphogenetic protein 2 (BMP-2) is known to up-regulate Igf-I gene expression, we hypothesized that PAPP-A may be involved in BMP-2 mechanisms in bone formation. To test this hypothesis, we quantified gene expression of Papp-A in response to BMP-2 treatment and Runx2, Osterix (Osx) and Igf-I in response to PAPP-A protein treatment in human adult mesenchymal stem cells (hMSC). Our results demonstrate that BMP-2 directly up-regulated Papp-A gene and protein expression. Purified PAPP-A protein directly up-regulated Runx2 and Igf-I gene expression, but not Osx. When added in combination with recombinant human BMP-2, PAPP-A increased matrix mineralization in the absence of dexamethasone. PAPP-A further demonstrated an angiogenic effect in the chick chorioallontoic membrane (CAM) which implicates a critical developmental role and possible therapeutic potential. Our findings suggest that PAPP-A functions in the formation of mineralized tissues through direct up-regulation of key genes. Further, PAPP-A is involved in the formation of new blood vessels which is essential for proper bone regeneration.",
keywords = "BMP-2, IGF-I, PAPP-A, Runx2",
author = "Julie Jadlowiec and Diana Dongell and Jason Smith and Conover, {Cheryl A} and Phil Campbell",
year = "2005",
month = "9",
doi = "10.1210/en.2004-1351",
language = "English (US)",
volume = "146",
pages = "3765--3772",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "9",

}

TY - JOUR

T1 - PAPP-A is involved in matrix mineralization of human adult mesenchymal stem cells and angiogenesis in the chick CAM

AU - Jadlowiec, Julie

AU - Dongell, Diana

AU - Smith, Jason

AU - Conover, Cheryl A

AU - Campbell, Phil

PY - 2005/9

Y1 - 2005/9

N2 - Pregnancy-associated plasma protein A (PAPP-A) is an insulin-like growth factor binding protein 4 (IGFBP-4) protease that can function to increase local IGF-I bioavailability. Aside from its assumed role during pregnancy, in vitro and in vivo studies have indicated roles for PAPP-A in IGF-I-mediated wound healing, vascular repair and bone formation. As bone morphogenetic protein 2 (BMP-2) is known to up-regulate Igf-I gene expression, we hypothesized that PAPP-A may be involved in BMP-2 mechanisms in bone formation. To test this hypothesis, we quantified gene expression of Papp-A in response to BMP-2 treatment and Runx2, Osterix (Osx) and Igf-I in response to PAPP-A protein treatment in human adult mesenchymal stem cells (hMSC). Our results demonstrate that BMP-2 directly up-regulated Papp-A gene and protein expression. Purified PAPP-A protein directly up-regulated Runx2 and Igf-I gene expression, but not Osx. When added in combination with recombinant human BMP-2, PAPP-A increased matrix mineralization in the absence of dexamethasone. PAPP-A further demonstrated an angiogenic effect in the chick chorioallontoic membrane (CAM) which implicates a critical developmental role and possible therapeutic potential. Our findings suggest that PAPP-A functions in the formation of mineralized tissues through direct up-regulation of key genes. Further, PAPP-A is involved in the formation of new blood vessels which is essential for proper bone regeneration.

AB - Pregnancy-associated plasma protein A (PAPP-A) is an insulin-like growth factor binding protein 4 (IGFBP-4) protease that can function to increase local IGF-I bioavailability. Aside from its assumed role during pregnancy, in vitro and in vivo studies have indicated roles for PAPP-A in IGF-I-mediated wound healing, vascular repair and bone formation. As bone morphogenetic protein 2 (BMP-2) is known to up-regulate Igf-I gene expression, we hypothesized that PAPP-A may be involved in BMP-2 mechanisms in bone formation. To test this hypothesis, we quantified gene expression of Papp-A in response to BMP-2 treatment and Runx2, Osterix (Osx) and Igf-I in response to PAPP-A protein treatment in human adult mesenchymal stem cells (hMSC). Our results demonstrate that BMP-2 directly up-regulated Papp-A gene and protein expression. Purified PAPP-A protein directly up-regulated Runx2 and Igf-I gene expression, but not Osx. When added in combination with recombinant human BMP-2, PAPP-A increased matrix mineralization in the absence of dexamethasone. PAPP-A further demonstrated an angiogenic effect in the chick chorioallontoic membrane (CAM) which implicates a critical developmental role and possible therapeutic potential. Our findings suggest that PAPP-A functions in the formation of mineralized tissues through direct up-regulation of key genes. Further, PAPP-A is involved in the formation of new blood vessels which is essential for proper bone regeneration.

KW - BMP-2

KW - IGF-I

KW - PAPP-A

KW - Runx2

UR - http://www.scopus.com/inward/record.url?scp=23844455346&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23844455346&partnerID=8YFLogxK

U2 - 10.1210/en.2004-1351

DO - 10.1210/en.2004-1351

M3 - Article

VL - 146

SP - 3765

EP - 3772

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 9

ER -